These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21197711)

  • 1. Xenograft of microencapsulated sertoli cells reverses T1DM in NOD mice by inducing neogenesis of beta-cells.
    Luca G; Fallarino F; Calvitti M; Mancuso F; Nastruzzi C; Arato I; Falabella G; Grohmann U; Becchetti E; Puccetti P; Calafiore R
    Transplantation; 2010 Dec; 90(12):1352-7. PubMed ID: 21197711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy.
    Ren B; O'Brien BA; Byrne MR; Ch'ng E; Gatt PN; Swan MA; Nassif NT; Wei MQ; Gijsbers R; Debyser Z; Simpson AM
    J Gene Med; 2013 Jan; 15(1):28-41. PubMed ID: 23293075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated functional maturation of isolated neonatal porcine cell clusters: in vitro and in vivo results in NOD mice.
    Luca G; Nastruzzi C; Calvitti M; Becchetti E; Baroni T; Neri LM; Capitani S; Basta G; Brunetti P; Calafiore R
    Cell Transplant; 2005; 14(5):249-61. PubMed ID: 16052907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenograft of microencapsulated Sertoli cells restores glucose homeostasis in db/db mice with spontaneous diabetes mellitus.
    Luca G; Arato I; Mancuso F; Calvitti M; Falabella G; Murdolo G; Basta G; Cameron DF; Hansen BC; Fallarino F; Baroni T; Aglietti MC; Tortoioli C; Bodo M; Calafiore R
    Xenotransplantation; 2016 Nov; 23(6):429-439. PubMed ID: 27678013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice.
    Chaillous L; Darquy S; Maugendre S; Rivereau AS; Reach G; Saï P
    Diabetologia; 1996 May; 39(5):523-9. PubMed ID: 8739911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pdxl and its role in activating Ngn3 and Pax6 to induce differentiation of iPSCs into islet β cells.
    Qin Y; Xiao L; Zhan XB; Zhou HX
    Genet Mol Res; 2015 Aug; 14(3):8892-900. PubMed ID: 26345820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice.
    Suarez-Pinzon WL; Power RF; Yan Y; Wasserfall C; Atkinson M; Rabinovitch A
    Diabetes; 2008 Dec; 57(12):3281-8. PubMed ID: 18835930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-TCRβ mAb in Combination With Neurogenin3 Gene Therapy Reverses Established Overt Type 1 Diabetes in Female NOD Mice.
    Xie A; Li R; Jiang T; Yan H; Zhang H; Yang Y; Yang L; Yechoor V; Chan L; Chen W
    Endocrinology; 2017 Oct; 158(10):3140-3151. PubMed ID: 28977608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo.
    de la Tour D; Halvorsen T; Demeterco C; Tyrberg B; Itkin-Ansari P; Loy M; Yoo SJ; Hao E; Bossie S; Levine F
    Mol Endocrinol; 2001 Mar; 15(3):476-83. PubMed ID: 11222748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone.
    Fallarino F; Luca G; Calvitti M; Mancuso F; Nastruzzi C; Fioretti MC; Grohmann U; Becchetti E; Burgevin A; Kratzer R; van Endert P; Boon L; Puccetti P; Calafiore R
    J Exp Med; 2009 Oct; 206(11):2511-26. PubMed ID: 19822646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological changes in insulin, glucagon and somatostatin cells in the islets of NOD mice during cyclophosphamide-accelerated diabetes: a combined immunohistochemical and histochemical study.
    Reddy S; Pathipati P; Bai Y; Robinson E; Ross JM
    J Mol Histol; 2005 May; 36(4):289-300. PubMed ID: 16200462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinoma-associated antigen-1 zinc-finger transcription factor promotes pancreatic duct cell trans-differentiation.
    Zhang T; Wang H; Saunee NA; Breslin MB; Lan MS
    Endocrinology; 2010 May; 151(5):2030-9. PubMed ID: 20215568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertoli cell line lacks the immunoprotective properties associated with primary Sertoli cells.
    Dufour JM; Dass B; Halley KR; Korbutt GS; Dixon DE; Rajotte RV
    Cell Transplant; 2008; 17(5):525-34. PubMed ID: 18714671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of diabetes in non-obese diabetic mice by xenografts of porcine islets entrapped in hollow fibres composed of polyacrylonitrile-sodium methallylsulphonate copolymer.
    Rivereau AS; Darquy S; Chaillous L; Maugendre S; Gouin E; Reach G; Sai P
    Diabetes Metab; 1997 Jun; 23(3):205-12. PubMed ID: 9233997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism.
    Suarez-Pinzon W; Korbutt GS; Power R; Hooton J; Rajotte RV; Rabinovitch A
    Diabetes; 2000 Nov; 49(11):1810-8. PubMed ID: 11078447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-fat diet induces early-onset diabetes in heterozygous Pax6 mutant mice.
    Chen Y; Feng R; Wang H; Wei R; Yang J; Wang L; Wang H; Zhang L; Hong TP; Wen J
    Diabetes Metab Res Rev; 2014 Sep; 30(6):467-75. PubMed ID: 24925705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodritin microencapsulated human islets of Langerhans and their potential for type 1 diabetes mellitus therapy.
    Campos-Lisbôa AC; Mares-Guia TR; Grazioli G; Goldberg AC; Sogayar MC
    Transplant Proc; 2008 Mar; 40(2):433-5. PubMed ID: 18374092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice.
    Li R; Buras E; Lee J; Liu R; Liu V; Espiritu C; Ozer K; Thompson B; Nally L; Yuan G; Oka K; Chang B; Samson S; Yechoor V; Chan L
    Gene Ther; 2015 Nov; 22(11):876-82. PubMed ID: 26172077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.